Journal article
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
Abstract
BackgroundAtazanavir/ritonavir and darunavir/ritonavir are common protease inhibitor-based regimens for treating patients with HIV. Studies comparing these drugs in clinical practice are lacking.MethodsWe conducted a retrospective cohort study of antiretroviral naïve participants in the Canadian Observational Cohort (CANOC) collaboration initiating atazanavir/ritonavir- or darunavir/ritonavir-based treatment. We used separate Fine and Gray …
Authors
Antoniou T; Szadkowski L; Walmsley S; Cooper C; Burchell AN; Bayoumi AM; Montaner JSG; Loutfy M; Klein MB; Machouf N
Journal
BMC Infectious Diseases, Vol. 17, No. 1,
Publisher
Springer Nature
Publication Date
December 2017
DOI
10.1186/s12879-017-2379-8
ISSN
1471-2334